D. E. Shaw & Co »

ADC Therapeutics SA shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $895k 284k 3.15
2024-06-30 $833k 264k 3.16
2024-03-31 $121k 27k 4.49
2020-09-30 $914k 28k 32.98

More positions owned by D. E. Shaw & Co

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
Booking Holdings (BKNG)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boeing Company (BA)
Eli Lilly & Co. (LLY)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Broadcom Call Option (AVGO)
Chipotle Mexican Grill (CMG)
Citigroup Com New (C)

View all positions for D. E. Shaw & Co

Top funds holding ADC Therapeutics SA

Redmile Group
Prosight Management
OrbiMed Advisors
BlackRock
Morgan Stanley
Woodline Partners
Silverarc Capital Management
Goldman Sachs Group
Platinum Investment Mangement
Bank of America Corporation
State Street Corporation
Siren
Geode Capital Management
UBS Group
Vantage Consulting Group

View all funds holding ADC Therapeutics SA